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Abstract
Background: The reduction of antimicrobial usage (AMU) is in the focus in modern pig production. The objective
of this study was to assess the effectiveness of alternatives to reduce AMU at herd level. In a prospective study, 68
farrow-to-finish pig herds located in Belgium, France, Germany and Sweden were recruited on a voluntary basis to
implement tailor-made intervention plans to reduce their AMU. Alternative measures included improvement of
biosecurity (n= 29 herds), vaccination (n= 30), changes of feeding schemes or drinking water quality (n= 45), improved pig
health and welfare care (n= 21) as well as changes in stable climate and zootechnical measures (n= 14). Herds were
followed for 1 year after implementation of measures. Annual antimicrobial expenditures or treatment records, as well as
disease incidence scores were collected and compared to those of the year before intervention. AMU was measured as the
treatment incidence and calculated by age category, antimicrobial class and administration route.
Results: Compliance with the intervention plans was high (median 93%). AMU was significantly reduced following
the implementation of alternative measures: in the median herd of the four countries, pigs were treated before
intervention 25% of their expected lifespan (200 days from birth to slaughter) and after intervention 16%. AMU of
suckling and weaned pigs were significantly reduced by 37 and 54%, respectively. The usage of polymyxins and
tetracyclines was significantly reduced by 69 and 49%, respectively. AMU via feed and water, as well as parenteral
AMU were significantly reduced by 46 and 36%, respectively. Herds with a higher AMU level before intervention
achieved a bigger reduction. The majority of disease incidence were similar before and after intervention, with a
few exceptions of disorders related to the gastro-intestinal tract in suckling pigs (decreased) and in breeding pigs
(increased).
Conclusion: Following tailor-made implementation of alternative measures, a substantial reduction of AMU in
pig production was achievable without jeopardizing animal health. The AMU reduction in the youngest age
categories (suckling and weaned pigs) and the reduction of group treatments via feed and water was in line with
the recent European Guidelines on the prudent use of antimicrobials in veterinary medicine.
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Background
To combat antimicrobial resistance (AMR) is a priority
for the European Commission [1]. Monitoring AMR and
AMU on national and regional level is of great import-
ance to create a comprehensive and reliable overview of
the development and spread of AMR. Several studies
identified clear associations between AMU and AMR in
both human and veterinary medicine [2–6]. In livestock
production, pig husbandry is one of the main sectors
using antimicrobials [7–9]. An abrupt removal or re-
striction of antimicrobials may have negative conse-
quences on animal health and welfare. After banning
antimicrobial growth promotor (AGP) use (1998–1999)
in Denmark farmers experienced a short-term increased
incidence of gastrointestinal disorders in weaned pigs
[10]. The unintended consequences from antimicrobial
use restrictions for disease treatment or prevention have
been assessed by several studies. Overall, the results in-
dicated, that the consequences were temporary and
minor [11–13]. Yet, further research is needed to assess
the impact on animal health and welfare from antimicro-
bial use restrictions and how these effects could be miti-
gated by improvements of animal health, management
and housing. Thus, disease preventing strategies are re-
quired to reduce AMU without subsequent increases in
disease frequencies. Whilst ensuring economic viability
and animal health, the demand on effectiveness and
practical feasibility of alternatives to antimicrobials is
high. Many alternatives have been described in literature,
but little is known about their effectiveness. The study
by Postma et al. 2015 [14] provided a list of possible al-
ternatives, which has been ranked by pig health experts
according to their expected effectiveness, feasibility and
return on investment. Most favoured alternatives were
the improvement of biosecurity measures, intensified
vaccination, the use of zinc/metals in feed, the improve-
ment of feed quality, the use of regular diagnostic testing
and a clear herd specific action plan based on diagnos-
tics and historical data. EFSA (European Food Safety
Authority) and EMA (European Medicines Agency) re-
leased a Joint Scientific Opinion on measures to reduce
the need of antimicrobial treatments in animal hus-
bandry in the EU and the resulting impacts on AMR
[15]. Even though national reduction strategies have
been successfully implemented in some Member States
and several alternatives to antimicrobials have been
studied, there is still a gap of knowledge in relation to
their effectiveness under field conditions. Moreover, the
multiplicity of factors contributing to AMU makes it dif-
ficult to quantify the impact of a single alternative meas-
ure on the AMU.
This publication was a result of data collected during
the MINAPIG project. The project was conducted to
evaluate strategies for raising pigs with minimal AMU in
four EU countries (Belgium, France, Germany and Sweden).
The objective of this study was to assess the impact of herd-
specific measures and associated compliance level on the
AMU level in farrow-to-finish farms. More specifically, the
aim was to explore the following questions: what AMU re-
duction can be achieved i) by age group, ii) by antimicrobial
class and iii) by administration route. Moreover, we investi-
gated the impact of the implementation of AMU-reducing
measures on pig health.
Materials and methods
Study design
Between February 2014 and August 2015 an intervention
study was conducted in 68 farrow-to-finish farms in four
EU countries. Farms were located in Belgium (n = 15),
France (n = 19), Germany (n = 25) and Sweden (n = 9).
Prior to the intervention study a cross-sectional study
had already been conducted in these countries [16–18].
The focus of the cross-sectional study was to explore the
relationship between AMU and farm management char-
acteristics, biosecurity practices and health status, as well
as farmer’s attitude and behaviour towards AMU. In
order to investigate the efficacy of the implementation of
alternative measures, AMU data from the cross-sectional
study and the intervention study were compared. Each
farm provided data on biosecurity measures, disease in-
cidence and antimicrobial expenditures or detailed treat-
ment records during a period of 12 months preceding
(antimicrobial usage data for France during the cross-
sectional study was only available for the last produced
batch) and 12 months following the initiation of the
intervention study. For the Swedish farms treatment re-
cords were only collected for three consecutive batches.
Each farm served as its own control (Fig. 1).
Recruitment of farms
Farms were primarily recruited among those who partic-
ipated in the cross-sectional study (Fig. 1). Inclusion cri-
teria were defined and only herds with at least 70 sows
and 500 fattening pigs produced per year participated in
this study. A total of 68 herds (Belgium n = 15, France
n = 19, Germany n = 25 and Sweden n = 9 herds) agreed
to participate in the intervention study (more details on
the recruitment procedure are presented in Additional
file 1). In Germany and Sweden, farmers received finan-
cial compensation for collecting and providing data, 200
€ and 1300€, respectively.
Data collection
Data from the cross-sectional study was available for 16
Belgian, 14 French, 19 German and six Swedish farms.
Details of the data collection in farms in the cross sec-
tional study was described in Sjölund et al. [17]. Briefly,
data on AMU of the participating herds was collected
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for one year preceding the herd visit in Belgium,
Germany and Sweden and for the last batch produced in
France. Information on AMU originated from invoices
from prescribing herd veterinarians or feed companies,
treatment records or from direct interview with the
farmer. Since 15 farms (additional farms: France n = 6;
Germany n = 6; Sweden n = 3) did not participate in the
cross-sectional study and were recruited specifically for
the intervention study, these farms were asked to pro-
vide data on AMU and disease incidence from the year
preceding the study (Fig. 1). During the intervention
study data on disease incidence and AMU was collected
for one year in Belgium, France and Germany. Herd vet-
erinarians in Belgium and France provided receipts of all
antimicrobial expenditures of the farm during the year
of follow-up. In Germany either the herd veterinarian or
farmer provided copies of the obligatory application and
dispensing records. Swedish veterinarians retrieved the
AMU data from herd treatment records as described by
Sjölund et al. (2015) for three consecutive farrowing
batches. For sows, AMU was only collected during the
nursing period [19]. The information on the receipts and
records included commercial product names, amount
and size of the antimicrobial packages. In Belgium and
France all prescribed antimicrobials were re-allocated by
the farmer to a given animal category, namely suckling
pigs, weaned pigs, fattening pigs or breeding pigs (i.e.
sows, gilts and boars). In Sweden this was retrieved from
the treatment records and in Germany the dispensing and
application form provided information on the treated ani-
mal category. To define a population at risk to receive
antimicrobial treatments, the average number of present
pigs per age category (i.e. suckling pigs, weaned pigs, fat-
tening pigs and breeding pigs) was collected from the farm
Fig. 1 Overview of the study setup
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management system or by interviewing the farmer. To
harmonize and improve data quality across the participat-
ing countries all collected data was entered in a Microsoft
Office Access© (version 2010) database.
Herd specific intervention plan and compliance
In Belgium, France and Germany, an initial herd visit,
together with the farmer, the herd veterinarian and the
project researcher was organized to define a herd specific
intervention plan. In Sweden the herds were either visited
initially by the herd veterinarian of the G&D or by one of
the two project researchers. Data and results from the
cross-sectional study were used as a basis for discussion
about options to reduce AMU. The alternatives were sum-
marized in six general categories for improvement namely
i) external biosecurity status (measures to prevent patho-
gens from entering into herd premises or a group of ani-
mals), ii) internal biosecurity status (measures to prevent
the spreading of pathogens within herd premises or a
group of animals), iii) herd vaccination scheme, iv) feed or
water quality or composition, v) pig health care (manage-
ment/focus on individual, vi) pig stable climate and other
zootechnical measures. In order to specify the alternative
measures each category was divided in predefined options
(Table 1). The most feasible and promising options to re-
duce AMU regarding the herd health problems were con-
sidered by the farmer and veterinarian. Subsequently, they
decided on type and number of options to implement.
Participating herds were visited at least twice and up to a
maximum of six times by a project researcher or the herd
veterinarian (for some of the Swedish herds). During the
visits, all issues related to the implemented measures were
discussed. If herd health or individual pig health was jeop-
ardized, the intervention was adjusted. Intermediate
phone calls with the herd veterinarian and farmer were
conducted to follow the development of the implemented
measures. To describe the compliance with the predefined
measures an average compliance score over the year of
follow-up per farm was computed for each measure. On
every follow up visit, farmers had to report on a scale from
1 (=no attempt to implement the measure) to 5 (=perfect
implementation), whether they followed the predefined
intervention plan. Scores were then converted into an
average percentage of compliance to the intervention plan
(i.e. total farm score × 100 / maximum achievable score).
Moreover, herd veterinarians and the project researcher
commented on the observed compliance. Their reports
corresponded to the score given by the farmer, so no
adjustments were made to the compliance reported by the
farmers.
Disease incidence
For information on the disease incidence, farmers were
asked about the average frequency of treatments (e.g.
antimicrobials, electrolytes, probiotics etc.) against cer-
tain disease symptoms per age category over the preced-
ing year. Annual data on the disease incidence from
both the cross-sectional study and the intervention study
was available in 15 Belgian, 13 French and 20 German
farms. In Sweden data on diseases was collected batch-
wise and expressed as a percentage. Thus, the Swedish
data was incomparable with the data from the other
countries and not included in the analysis. In the inter-
vention study, farmers were asked to provide these data
by the end of the study. Median disease incidence scores
before and after the intervention study were compared
for each age category.
Quantification of AMU
For the detailed analysis of the AMU, antimicrobial treat-
ment data were converted into a `treatment incidence`
(TI). The TI expresses the number of animals out of a
1000 being treated with a daily dose of antimicrobials or,
when divided by 10, the percentage of their life expectancy
they are treated with one daily dose of antimicrobials [20].
Previously developed defined daily doses animal (DDDA’s)
harmonized for the MINAPIG project were used for cal-
culating the TI and originated from a consensus DDDA
list previously published [21]. The period at risk for each
animal category was defined as the time period a pig could
receive an antimicrobial treatment. For breeding animals,
it was set to 365 days, for suckling, weaned and fattening
pigs the rearing periods of the individual herds were used.
Since the Swedish herds provided data from three con-
secutive batches the risk period for the breeding sows was
adapted accordingly. This means that the period at risk
for a “batch” of sows was set to 158.7 days (365 days di-
vided by 2.3, the average number of farrowings per sow
per year [22]). In order to enhance comparability between
farms, harmonized weights for the animal categories (in
kilogrammes) were defined, namely: two kg for suckling
pigs, seven kg for weaned pigs, 35 kg for fattening pigs, 60
kg for gilts and 220 kg for sows [17]. Moreover, the TI of
suckling, weaned and fattening pigs were combined into a
`TI 200 days` (TI200d), assuming an expected lifespan of
200 days. Hence, the standardised TI200d corrected for
possible differences in ages at slaughter between the par-
ticipating farms (for details see Sjölund et al. (2016) [17]).
Furthermore, a TI for each antimicrobial class, namely:
third generation cephalosporines, aminoglycosides,
aminopenicillins, benzylpenicillins, benzylpenicillins-
combinations, florfenicols, fluorquinolones, macrolides,
macrolide-combinations, polymyxins, pleuromutilins, tet-
racyclines and trimethoprim-sulfonamides, and adminis-
tration route (oral and parenteral) was computed for every
farm. Treatment incidences of topical products were ex-
cluded from the analysis because they represented a negli-
gible part of AMU.
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Data processing and statistical analysis
For the purpose of analysing the effect of different al-
ternative measures, median TIs and median disease
incidence scores before and after the intervention
study were compared using non-parametric Wilcoxon
signed-rank testing. A p-value of 0.05 was used as a
significance threshold. Spearman rank correlation was
used to test for associations between treatment inci-
dence scores before and after intervention. Descriptive
and analytical statistics were performed using the
open-source environment R 3.0.2 (R Core Team,
2013, www.r-project.org).
Results
Herd specific intervention plans and compliance
A total of 70 herds were enrolled in the intervention
study, but two herds were lost from follow-up due to
farmers’ personal issues (n = 1) and due to changing herd
veterinarian, who was not willing to participate (n = 1).
Changes in feed or water quality or composition (n = 45)
was the most commonly implemented intervention
(Table 1). The most common option in this category
was the implementation of therapeutic zinc oxide in the
feed for piglets (n = 18). In 11 Belgian herds zinc oxide
was added to the post-weaning feed at 2500 ppm for 10
to 14 days. This option was only possible due to a
change in legislation shortly before the start of the study
(September 2013), which authorized the therapeutic use
of zinc oxide [23]. In Germany, seven herds added zinc
oxide at 150 ppm for seven to 14 days post-weaning in-
stead of using a combination of colistin and zinc. The
median compliance percentage for the last-mentioned
category was the highest (100%), whereas the compliance
for improvement options in the category ‘external biose-
curity’ was the lowest (73%) (Table 1).
Disease incidence score before and after intervention
For the comparison of median disease incidence scores
before and after the intervention study, a total of 48
herds were considered in the analysis (Belgium n = 15;
France n = 13; Germany n = 20) (Table 2). Treatment
frequencies of breeding pigs against disorders of the cen-
tral nervous system and gastrointestinal tract increased
during the intervention study (p < 0.001), whereas treat-
ments against skin diseases (p = 0.04) and udder diseases
decreased (p = 0.03). Suckling pigs were more frequently
treated against disorders of the central nervous system in the
intervention study (p < 0.001), but treatments against disor-
ders of the gastrointestinal tract decreased (p < 0.001). Treat-
ment frequency of weaned pigs against disorders of the
locomotor system decreased during the intervention study
(p = 0.01). Fattening pigs were more frequently treated
against disorders of the gastrointestinal tract during the inter-
vention study (p = 0.02) (Table 2).
Treatment incidences per age category before and after
intervention
For the analysis of the AMU before and after the inter-
vention study, 14 Belgian, 19 French, 25 German and
nine Swedish herds were included. One Belgian farm
was excluded from the analysis due to un-reliable data.
Median TIs in the different age categories, antimicrobial
classes and administration routes differed between and
within countries (see Additional file 2). Following the
implementation of interventions, AMU was significantly
reduced. In the median herd of the four countries, pigs
were treated during 25% of the expected lifespan before
the intervention (TI200d: 247.3) and during 16% of the
expected lifespan after the intervention (TI200d: 160.2)
(p < 0.001), which is a reduction of 35% (Table 3). More-
over, treatment incidences of suckling and weaned pigs
were significantly (p < 0.001) reduced by 37 and 54%, re-
spectively (Table 3). In the fattening and breeding pigs,
no significant changes were observed.
Treatment incidences per antimicrobial class and
administration route before and after intervention
The usage of some critically important antimicrobials for hu-
man medicine (i.e. fluoroquinolones and 3rd generation
cephalosporins) was reduced significantly (Table 4), especially
in Belgium (TI for 3rd generation cephalosporins before:
83.9; after: 0.7) (see Additional file 2). In the median herd of
the four countries, TIs of polymyxins (critically important
antimicrobial for human medicine) and tetracyclines were
significantly reduced (TI polymyxins: p < 0.001; TI tetracy-
clines: p= 0.01) with a median of 106.8 and 50.7 before the
interventions and 33.2 (69% reduction) and 26.1 (49% reduc-
tion) after the interventions (Table 4), respectively. TIs for
macrolides decreased in France, Germany and Sweden,
whereas the usage increased in Belgium (before: 2.5; after:
27.5) (see Additional file 2). Usage of benzylpenicillin-
combinations was significantly (p= 0.01) reduced (Table 4);
this was mainly influenced by Germany, where the max-
imum TI before the intervention was 9.9 and after the inter-
vention 0.0 (see Additional file 2). Median treatment
incidences over the four countries for feed/water and paren-
teral administrations were significantly reduced by 46% and
36% after implementation of interventions (TI feed-water:
p < 0.001; TI parenteral: p= 0.01) (Table 4).
Correlation of the achieved TI200d reduction
Figure 2 illustrates the correlation between the change
in TI200d (TI200d after-TI200d before = TI200d
reduction) and the TI200d before intervention in the
participating herds. Herds with a higher AMU before
intervention achieved a larger reduction (Spearman
rank correlation coefficient ρ = 0.74). In some herds
the AMU increased after implementing interventions
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(17/67) while other herds managed a substantial re-
duction (50/67) (Fig. 2).
Discussion
Interventions and compliance
In this study the suggested interventions to reduce AMU
were inspired by herd specific problems and diagnostic
results each herd experienced by the time of the visits. It
was hypothesized that implementing a predefined uni-
versal intervention plan for all participating herds would
have led to a poor compliance and a poor effect on
AMU as some interventions would have been unneces-
sary. The significant reduction of AMU was rather the
overall effect of the implemented measures and cannot
be extrapolated to individual measures. Moreover, a key
element of a good compliance was the coaching/guid-
ance of the farmer throughout the follow-up year and a
close cooperation between herd veterinarian, farmer and
external coach, as previously suggested by Postma et al.
[24]. The median compliance score of the different cat-
egories of improvement was relatively high, ranging from
73% (internal biosecurity) to 100% (pig stable climate
and other zootechnical measures). The willingness of
farmers to make adjustments on their farm might de-
pend on its economic benefit. Especially implementing
or altering biosecurity measures are believed to be
Table 1 Distribution of alternative measures in the participating herds (n = 68) and median compliance percentage per category
General categories for improvement
(number of farms)
Options for improvement
(number of included measures)a
Median compliance
percentage in general category (Min-Max)
External biosecurity (n = 9) Purchasing policy/gilts acclimatisation (n = 8) 73 (20–100)
Removing of animal carcasses (n = 2)
Vermin control (n = 1)
Internal biosecurity (n = 20) Suckling period management (n = 9) 75 (0–100)
Farm compartmentalising, working lines (n = 6)
Cleaning and disinfection (n = 6)
Vaccination scheme (n = 30) Altering of existing vaccination protocols (n = 5) 88 (0–100)
Implementation of a new vaccination (n = 29)
Feed or water quality or composition
(n = 45)
Feed additives zinc/metal (n = 18) 87 (0–100)
Feed scheme revision (n = 10)
Feed and water acidification (n = 12)
Cleaning and disinfection of water pipes (n = 7)
Feed additives phytotherapy and other additives (n = 14)
Feed quality improvement (e.g. change in fat, protein or fibre
content) (n = 5)
Feed additives pre- and probiotics (n = 4)
Water quality control (n = 3)
Pig health care (n = 21) Increased diagnostics (n = 7) 89 (0–100)
Alternative treatments protocols in case of symptoms
(e.g. with anti-inflammatory products or prostaglandins) (n = 5)
Revision of deworming scheme (n = 4)
Stopping surgical castration (n = 3)
Hospital pens put in place (n = 3)
Euthanasia of runt suckling piglets (n = 1)
Pig stable climate and other zootechnical
measures (n = 14)
Climate adjustments (n = 7) 100 (20–100)
Change of genetics (n = 2)
Animal transfer adjusted (avoidance of re-mixing of piglets
or having pens with heterogeneous pigs (n = 4)
Building renovations (n = 3)
Reduced pig density (n = 2)
Farrowing processed slowed down (n = 2)
aThe number of included options is higher than the number of participating farms, because farmers and herd veterinarians decided to implement one or multiple
options from one or several categories
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expensive or impractical [25, 26]. Therefore, it might be
easier for the farmer to implement direct changes to a
feeding scheme (e.g. add zinc oxide to the post-weaning
feed) rather than alter daily habits related to biosecurity
(for internal biosecurity e.g. change working lines). Yet,
this perception is not necessarily true since different
studies clearly demonstrated, that altering biosecurity
measures on farms is feasible and beneficial [16, 27]. An-
other barrier which influenced the compliance was the
need to train farm workers, especially on larger farms.
Some of the interventions required a strict adherence to
work processes. Therefore, all employees needed to be
encouraged and trained to harmonize their workflow.
Collineau et al. (2017) showed that farms with higher
compliance to the intervention measures tended to
achieve bigger AMU reduction [28].
Disease incidence
A substantial reduction of AMU on herd level was
achievable without major impact on pig health. The
Table 3 Comparison of median treatment incidences (TI) for different age categories before and after intervention (n = 67)
Parameter Median before intervention
(Q25; Q75)
Median after intervention
(Q25; Q75)
p-valuea Difference in percentage (%)
TI suckling pigs 279.9 (158.0; 484.6) 176.2 (80.2; 391.7) < 0.001 − 37
TI weaned pigs 568.0 (113.1;1072.3) 261.2 (54.4; 573.1) < 0.001 −54
TI fattening pigs 8.0 (0.8;37.7) 7.7 (0.8; 44.0) 0.89 −3
TI200d 247.3 (92.7; 451.8) 160.2 (59.7; 303.6) < 0.001 −35
TI breeding pigs 14.0 (4.5; 32.0) 17.1 (4.2; 45.3) 0.5 + 18
a Wilcoxon signed rank test (n = 67 farrow-to-finish herds). Significant (p < 0.05) results are highlighted in bold
Table 2 Comparison of median disease incidence scoresa per age categories before and after intervention (n = 48)
Age category Disorders of Median before intervention
(Q25; Q75b)
Median after intervention
(Q25; Q75)
p-valuec
Suckling pigs locomotor system 3 (2; 4) 3 (2; 3) 0.36
gastro-intestinal tract system 3 (2; 4) 1 (1; 2) < 0.001
respiratory tract system 1 (1; 2) 1 (1; 2) 0.55
central nervous system 1 (1; 2) 2 (2; 3) < 0.001
skin 1 (1; 2) 1 (1; 2) 0.92
Weaned pigs locomotor system 3 (2; 4) 3 (2; 3) 0.01
gastro-intestinal tract system 2 (1; 4) 2 (2; 3) 0.19
respiratory tract system 2 (1; 3) 2 (1; 3) 0.97
central nervous system 2 (2; 3) 3 (2; 4) 0.24
skin 2 (1; 2) 2 (2; 3) 0.18
Fattening pigs locomotor system 2 (2; 3) 2 (2; 3) 0.45
gastro-intestinal tract system 1 (1; 2) 2 (2; 3) 0.02
respiratory tract system 2 (1; 3) 2 (1; 3) 0.84
central nervous system 1 (1; 2) 1 (1; 2) 0.11
skin 1 (1; 2) 1 (1; 2) 0.08
Breeding pigs locomotor system 2 (2; 3) 3 (2; 3) 0.70
gastro-intestinal tract system 1 (1; 1) 1 (1; 2) < 0.001
respiratory tract system 1 (1; 2) 2 (1; 2) 0.60
central nervous system 1 (1; 1) 1 (1; 1) 0.02
skin 1 (1; 2) 1 (1; 1) 0.04
reproductive tract system 2 (2; 3) 2 (2; 3) 0.80
udder 2 (2; 3) 2 (2; 3) 0.03
aScores are composed of a five-point Likert scale (1 = never, 2 = rarely; 3 = occasionally; 4 = regularly; 5 = commonly/always). Significant (p < 0.05) results are
highlighted in bold
b25th and 75the quartiles
cWilcoxon signed rank test (n = 48 farrow-to-finish herds)
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estimated treatment frequency against predefined cat-
egories of disease symptoms before and after the inter-
vention study was used as a proxy of disease incidence
in the different age categories. It should be noted that
the sample size for this analysis was small and a five-
point scale is not a very discriminative parameter. None-
theless, we observed a significant reduction in the anti-
microbial usage of suckling pigs and at the same time a
significant reduction of symptoms related to gastro-
intestinal diseases. Since neonatal porcine diarrhoea
Table 4 Comparison of median treatment incidences (TI) for different antimicrobial classes and administration route before and
after intervention (n = 67)
Parameter Median before intervention
(Q25; Q75)
Median after intervention
(Q25; Q75)
p-valuea Difference in percentage (%)
TI 3rd generation cephalosporins 0 (0.0; 10.3) 0 (0.0; 1.1) 0.09 0
TI Aminoglycosides 0 (0.0; 0.7) 0 (0.0; 0.6) 0.24 0
TI Aminopenicillins 139.6 (20.2; 414.0) 136.0 (15.9; 350.3) 0.19 −3
TI Benzylpenicillin 0 (0.0; 14.5) 0 (0.0; 17.8) 0.62 0
TI Benzylpenicillin-combinations 0 (0.0; 14.5) 0 (0.0; 5.6) 0.01 0
TI Florfenicols 0 (0.0; 0.0) 0 (0.0; 0.5) 0.81 0
TI Fluorquinolones 9.5 (3.7; 27.3) 7.6 (1.0; 28.0) 0.15 −20
TI Macrolides 12.6 (0.3; 208.7) 12.4 (0.0; 203.4) 0.84 −1
TI Macrolide-combinations 0 (0.0; 0.6) 0 (0.0; 0.2) 0.12 0
TI Pleuromutilins 0 (0.0; 0.0) 0 (0.0; 0.0) 0.18 0
TI Polymyxins 106.8 (1.1; 467.8) 33.2 (0.0; 155.4) < 0.001 −69
TI Tetracyclines 50.7 (0.2; 255.1) 26.1 (0.1; 107.1) 0.01 −49
TI Trimethoprim-Sulfonamides 2.3 (0.0; 30.4) 0.1 (0.0; 22.8) 0.60 − 96
Administration route parenteral 300.0 (141.2; 493.4) 192.5 (111.7; 406.3) 0.01 −36
Administration route feed/water 601.3 (69.8; 1295.7) 322.0 (77.4; 632.2) < 0.001 −46
aWilcoxon signed rank test (n = 67 farrow-to-finish herds). Significant (p < 0.05) results are highlighted in bold
Fig. 2 Correlation of the achieved TI200d reduction. Herds with a higher AMU before intervention achieved a larger reduction. Legend: Correlation
between achieved reduction of the treatment incidence of growing pigs from birth to slaughter with a standardised life span of 200 days (TI200d
after-TI200d before) and treatment incidence before (TI200d before) intervention in Belgian (n = 14), French (n = 20), German (n = 25) and Swedish
(n = 9) farrow-to-finish pig herds. (Spearman rank correlation coefficient ρ = − 0.53)
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(NPD) is a common clinical condition in new-born pig-
lets, some of the implemented alternative measures (e.g.
improved feed and water quality, optimisation colostrum
supply via split-suckling management) focused on this
problem [29, 30].
The treatment against diseases of the central nervous
system in piglets increased. A possible explanation for
this effect could be that farmers focussed on individual
treatments during the interventions. Thus, they intensi-
fied the observation of sick and diseased animals and re-
ported more treatments against diseases of the central
nervous system.
During the intervention period, farmers also observed
a reduction of disease symptoms related to disorders of
the locomotor system in weaned pigs. Participating
farms with a known history of reoccurring polyarthritis
outbreaks in weaned pigs improved hygiene protocols in
the farrowing and nursing unit such as intensified disin-
fection with an appropriate disinfectant and/or changed
needles and castration blades between litters. These
measures reduce the transmission of infectious agents
and have been recommended as useful intervention
strategies in previous studies [31]. Moreover, some farms
introduced autogenous vaccines in the sows pre-
farrowing in order to provide new-born piglets with
maternal antibodies. Immunization of sows has been re-
ported as an effective control strategy to reduce neuro-
logical signs, depression and microscopic lesions of
meningitis due to a Streptococcus suis infection in
weaned pigs [32]. The target in farms with reoccurring
polyarthritis outbreaks in weaned pigs was to reduce the
oral medication with amoxicillin for entire batches in
the nursery period.
In breeding pigs, farmers observed more gastro-
intestinal disorders during the intervention study. This
may be linked to the introduction of the Porcine Epi-
demic Diarrhoea Virus (PEDV) in 2014 in Germany
[33]. In fact, one German farm experienced a severe
PEDV outbreak during the intervention study. As a re-
sult, farmers might have been more sensitive to the ob-
servation and treatment of gastro-intestinal symptoms
like diarrhoea in the breeding pigs. This might be
reflected in the TI breeding pigs in Germany which in-
creased by 75% (before intervention: 10.3; after interven-
tion: 41.2).
AMU reduction
The median treatment incidence in the youngest pigs
was reduced by 37% (i.e. suckling pigs), in weaned pigs
by 54%, in fattening pigs by 3% and in pigs from birth till
slaughter (TI200d) by 35%. The significant reduction,
mainly in suckling and weaned pigs, could be explained
by the fact that, among the participating countries, espe-
cially suckling and weaned pigs received most of the
antimicrobial treatments before the intervention and
were hence targeted in priority by the implemented al-
ternative measures. This is in line with other studies,
where especially weaned pigs receive most of antimicro-
bial treatments [7, 9, 17, 34, 35]. Callens et al. (2012) re-
ported that 90% of oral group treatment was
administered between birth and 10 weeks of age (farrow-
ing and nursery period). The main indication for orally
administered colistin and amoxicillin was post-weaning
E. coli (Escherichia coli) infections (colistin) and prevent-
ive treatments against streptococcal infections (amoxicil-
lin) [7]. A more recent study by Sarrazin et al. (2018)
observed peaks in frequency of treatment during weeks
one, four and nine of the rearing period [9]. In accord-
ance with Sjölund et al. (2016) it is suggested, that pigs
are often treated at strategic time points (castration in
week one, weaning at week 4 and beginning of fattening
period in week 9), when they are more prone to become
infected [19]. Moreover, a higher AMU at a younger age
was associated with a higher use in older pigs. Thus, the
reduction of AMU should already start in the suckling
period, as this seemed to affect the AMU in the con-
secutive weaning and fattening period [9]. A study by
Diana et al. (2017) demonstrated, that rearing pigs
without preventive antimicrobial treatment in the
weaning period is possible without jeopardising ani-
mal health and welfare indicators, which is in line
with our study [36].
Group treatments via feed or water were commonly
applied before the intervention in Belgium, France and
Germany. In contrast, in the Swedish pig herds there
were almost no group treatments through feed and
water and these herds accounted for the lowest AMU
before and after the intervention. The variations between
countries could be partly explained by differences in
prevalence of pathogens, like Porcine Reproductive and
Respiratory Syndrome Virus (PPRSV). Sweden is de-
clared free of PRRSV and pig herds are not exposed to
severe diseases and consequences concomitantly caused
by a PRRSV infection. Moreover, pig and herd density
may influence transmission between herds and Sweden
has a low pig density compared to the other participat-
ing countries [17]. In this study participating herds in-
cluded measures to avoid the treatment of entire batches
and tried to focus the treatment of single individuals
within a batch. Treatment of entire batches with antimi-
crobials via oral route increases consumption compared
to medication of individual animals [17]. The results of
this study showed, however, that treatment incidences
for both administration routes were significantly re-
duced. The early parenteral treatment of diseased indi-
vidual animals resulted in a reduced need of oral applied
antimicrobial therapy of a whole group of animals. Re-
moval of unnecessary use was another key element of
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the AMU reduction in this study (e.g. omitting the treatment
of suckling pigs with benzylpenicillin after surgical castration
or omitting the application of polymyxins in feed or water
after weaning piglets to prevent post weaning diarrhoea
(PWD)). A significant reduction of 69% was observed for
polymyxins (almost entirely colistin). According to the ninth
ESVAC report, the sales of polymyxins decreased by 66.4%
during 2011–2017 over 31 reporting countries [37]. The
more pronounced reduction in the use of polymyxins in this
study is likely due to the application of zinc oxide as an alter-
native for colistin in the treatment of PWD in weaned pigs.
Additionally, the extra interventions (e.g. changes in feed or
water quality or composition) and intensive coaching en-
hanced the effect on a reduced use of polymyxins. Even
though these additives showed to have a positive effect on
the gut health in young pigs, there is an increasing concern
that high doses of zinc oxide leads to an increased prevalence
of AMR in bacteria in weaned pigs and cause an environ-
mental burden [15]. Therefore, the EMA decided to ban the
therapeutic use of zinc oxide in feed by 2022 at the latest
[38]. This may cause an increase in AMU following the ban
unless alternative measures are implemented. The observed
reduction of critically important antimicrobials (CIA) espe-
cially in Belgian herds demonstrated that the application of
preventive measures instead of (routine) use of prophylactic
treatments with highly potent antimicrobial classes was feas-
ible. This is in line with the recent results of the BELVET-
SAC report (2018), which demonstrated a very substantial
reduction in the sales of 3rd and 4th generation cephalospo-
rins and fluoroquinolones (79.1%) between 2011 and 2018
[39]. The results showed that especially herds with a high
AMU before the intervention could achieve a bigger reduc-
tion of AMU during the intervention study. All participating
farms were approached with benchmarked results of the
cross-sectional study. This is in line with the policy in several
EU member states that already use benchmarking of anti-
microbial use as a key tool to trigger reduction strategies on
herd level [15]. Moreover, the willingness to implement alter-
native strategies might be more present when there is more
need for improvement (e.g. herds with a high AMU). Coun-
tries with AMU monitoring systems successfully reduced
AMU for many reasons. But one main reason might be the
improved awareness in both society and agricultural sector.
Consequently, the pressure to move towards a more prudent
AMU was increased on farms with a high AMU. In contrast
farms with a correspondingly low AMU might be hesitant to
change their management practices and perceive less need to
contribute towards a lower AMU in their herds.
Study design
Since it was difficult to provide control farms to com-
pare with intervention farms, it was decided that each
farm served as its own control. The definition of the
control herd was the particular limitation of the
experimental design of the study. As pig farming re-
quires a constant adjustment of management practices
related to the herd health status. Finding farms not
changing their practices over one year was considered
impossible. Thus, using each herd as its own control was
the most suitable approach in this study. For each herd
there was a different intervention implemented, which
was tailor-made to its specific health and production
situation. This approach was used to maximize the ex-
pected efficacy of the intervention, as well as the compli-
ance with recommended measures. Moreover, this study
was performed under uncontrolled settings, and could
be biased by factors external to the intervention. The
comparison of selected outcome variables before and
after intervention (AMU, disease incidence) was pos-
sible, because detailed data from the year proceeding the
interventions study was available for each participating
farm. One of the main limitations of the present study
relates to the way of applying a direct comparison be-
tween groups (non-parametric comparison of medians).
During the study most of the technical information, anti-
microbial usage and information on the disease inci-
dence were collected on two time points: the last batch
produced before the implementation of the intervention
and at the end of the study. The last batch produced,
was used as the reference to evaluate the impact of the
intervention. In order to improve data quality and ana-
lysis different statistical tools, such as statistical process
control (SPC) could be used. But in order to perform
such an analysis, a time series data collection with
graphical presentation of data would be needed. This
would allow more insights into the data and show an
improvement of defined processes. During the study
predefined parameters were not monitored and collected
on each herd visit, in order to establish a control chart,
which could have been used for analysing the data with
SPC. Moreover, the key element of implementing
alternatives and the subsequent AMU reduction was the
coaching of the farmer on a foundation of trust, which
was not measurable. Thus, the most challenging and
time-consuming part of the study was to convince
farmers to alter management procedures. Therefore, the
effort to convince farmers to take part in both studies
was expectably high. Moreover, the participation
depended on voluntary basis and maybe these farmers
were in general more interested and hence represented
the better performing herds or perceived a higher need
to reduce AMU (e.g. herds with a high AMU). As a fu-
ture perspective, applying similar approaches to larger
farmer populations is needed.
Conclusion
A reduction of AMU on herd level was achievable with-
out major impact on pig health. The results of this study
Raasch et al. Porcine Health Management             (2020) 6:6 Page 10 of 12
demonstrated that the effect of the interventions on the
AMU was rather the conglomeration of herd specific al-
ternative measures and cannot be summarized to a sin-
gle strategy (‘silver bullet’) that would be effective in
every farm. Knowledge about risk factors for a higher
AMU, benchmarking of AMU on farms, accompanied
by a package of herd-specific reduction measures play a
substantial role in the challenge to reduce AMU. Tailor-
made interventions and a close cooperation with the
herd veterinarian showed to be key determinants to
jointly address the challenges in the reduction of AMU
and prudent use of antimicrobials. To achieve the most
substantial effect especially the suckling and weaned pigs
should be targeted in priority for interventions. Besides
an optimisation of biosecurity practices, a reduction of
group treatments via feed and water through improved
health and an increased awareness of treatment and care
for individual animals should be included in possible
intervention strategies.
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